Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma
- PMID: 38792023
- PMCID: PMC11120020
- DOI: 10.3390/cancers16101945
Immunohistochemical Investigation into Protein Expression Patterns of FOXO4, IRF8 and LEF1 in Canine Osteosarcoma
Abstract
Osteosarcoma (OSA) is the most common type of primary bone malignancy in people and dogs. Our previous molecular comparisons of canine OSA against healthy bone resulted in the identification of differentially expressed protein-expressing genes (forkhead box protein O4 (FOXO4), interferon regulatory factor 8 (IRF8), and lymphoid enhancer binding factor 1 (LEF1)). Immunohistochemistry (IHC) and H-scoring provided semi-quantitative assessment of nuclear and cytoplasmic staining alongside qualitative data to contextualise staining (n = 26 patients). FOXO4 was expressed predominantly in the cytoplasm with significantly lower nuclear H-scores. IRF8 H-scores ranged from 0 to 3 throughout the cohort in the nucleus and cytoplasm. LEF1 was expressed in all patients with significantly lower cytoplasmic staining compared to nuclear. No sex or anatomical location differences were observed. While reduced levels of FOXO4 might indicate malignancy, the weak or absent protein expression limits its primary use as diagnostic tumour marker. IRF8 and LEF1 have more potential for prognostic and diagnostic uses and facilitate further understanding of their roles within their respective molecular pathways, including Wnt/beta-catenin/LEF1 signalling and differential regulation of tumour suppressor genes. Deeper understanding of the mechanisms involved in OSA are essential contributions towards the development of novel diagnostic, prognostic, and treatment options in human and veterinary medicine contexts.
Keywords: cancer identification; forkhead box protein O4; interferon regulatory factor 8; lymphoid enhancer binding factor 1; osteosarcoma; pathology.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.BMC Vet Res. 2012 Jun 11;8:78. doi: 10.1186/1746-6148-8-78. BMC Vet Res. 2012. PMID: 22686277 Free PMC article.
-
Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.Cell Physiol Biochem. 2018;51(2):961-978. doi: 10.1159/000495399. Epub 2018 Nov 22. Cell Physiol Biochem. 2018. PMID: 30466106
-
Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.Mod Pathol. 2011 Nov;24(11):1433-43. doi: 10.1038/modpathol.2011.103. Epub 2011 Jun 17. Mod Pathol. 2011. PMID: 21685909
-
Forkhead box O4 transcription factor in human neoplasms: Cannot afford to lose the novel suppressor.J Cell Physiol. 2019 Jun;234(6):8647-8658. doi: 10.1002/jcp.27853. Epub 2018 Dec 4. J Cell Physiol. 2019. PMID: 30515801 Review.
-
Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.Front Cell Dev Biol. 2021 Dec 20;9:750084. doi: 10.3389/fcell.2021.750084. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34988073 Free PMC article. Review.
Cited by
-
Comparison of Differentially Expressed Genes in Human and Canine Osteosarcoma.Life (Basel). 2025 Jun 12;15(6):951. doi: 10.3390/life15060951. Life (Basel). 2025. PMID: 40566602 Free PMC article.
References
-
- Schmidt A.F., Groenwold R.H.H., Amsellem P., Bacon N., Klungel O.H., Hoes A.W., de Boer A., Kow K., Maritato K., Kirpensteijn J., et al. Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis. Prev. Vet. Med. 2016;125:116–125. doi: 10.1016/j.prevetmed.2015.10.016. - DOI - PubMed
-
- Greene S. Withrow & MacEwen’s Small Animal Clinical Oncology, 6th edition. Am. J. Vet. Res. 2020;81:391.
Grants and funding
LinkOut - more resources
Full Text Sources